Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2024

13.01.2024 | Review

Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites

verfasst von: Joyce Badal, Bryan Badal, Mohamad Nawras, Wade Lee-Smith, Sara Stanley, Mona Hassan, Zohaib Ahmed

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Spontaneous bacterial peritonitis (SBP) is the most common infection in patients with cirrhosis and is associated with high mortality. Although recent literature reports mortality benefits to early diagnostic paracentesis, current guidelines do not offer specific recommendations for how quickly diagnostic paracentesis should be performed in patients with cirrhosis and ascites who are admitted to the hospital. Therefore, we conducted a systematic review and meta-analysis to evaluate outcomes among patients admitted to the hospital with cirrhosis and ascites receiving paracentesis within ≤ 12, ≤ 1 day, and > 1 day. Eight studies with 116,174 patients were included in the final meta-analysis. The pooled risk of in-hospital mortality was significantly lower in patients who underwent early (≤ 12 h or ≤ 1 day) compared to delayed (> 12 h or > 1 day) paracentesis (RR: 0.69, p < 0.00001), and in patients who underwent paracentesis compared to no paracentesis (RR: 0.74, p < 0.00001). On subgroup analysis, in-hospital mortality was significantly lower in both paracentesis within ≤ 12 h (RR: 0.61, p = 0.02) vs. > 12 h, and within ≤ 1 day (RR: 0.70, p < 0.00001) vs. > 1 day. While there was a trend towards decreased mortality in those undergoing paracentesis within ≤ 12 h compared to ≤ 1 day, the difference did not reach statistical significance. The length of hospital stay was significantly shorter by 5.38 days in patients who underwent early (≤ 12 h) compared to delayed (> 12 h) paracentesis (95% CI 4.24–6.52, p < 0.00001). Early paracentesis is associated with reduced mortality and length of hospital stay. We encourage providers to perform diagnostic paracentesis in a timely manner, at least within 1 day of hospital admission, for all patients with cirrhosis and ascites.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2011;9:260–265.CrossRefPubMed Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2011;9:260–265.CrossRefPubMed
2.
Zurück zum Zitat Planas R, Montoliu S, Balleste B et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385–1394.CrossRefPubMed Planas R, Montoliu S, Balleste B et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385–1394.CrossRefPubMed
3.
Zurück zum Zitat Rimola A, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000;32:142–153.CrossRefPubMed Rimola A, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol. 2000;32:142–153.CrossRefPubMed
4.
Zurück zum Zitat Piano S, Singh V, Caraceni P et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156:1368-1380.e10.CrossRefPubMed Piano S, Singh V, Caraceni P et al. Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology. 2019;156:1368-1380.e10.CrossRefPubMed
5.
Zurück zum Zitat Chinnock B, Afarian H, Minnigan H et al. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis. Ann Emerg Med. 2008;52:268–273.CrossRefPubMed Chinnock B, Afarian H, Minnigan H et al. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis. Ann Emerg Med. 2008;52:268–273.CrossRefPubMed
6.
Zurück zum Zitat Chinnock B, Hendey GW, Minnigan H et al. Clinical impression and ascites appearance do not rule out bacterial peritonitis. J Emerg Med. 2013;44:903–909.CrossRefPubMed Chinnock B, Hendey GW, Minnigan H et al. Clinical impression and ascites appearance do not rule out bacterial peritonitis. J Emerg Med. 2013;44:903–909.CrossRefPubMed
7.
Zurück zum Zitat Mumtaz K, Ahmed US, Abid S et al. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010;20:514–518.PubMed Mumtaz K, Ahmed US, Abid S et al. Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis. J Coll Physicians Surg Pak. 2010;20:514–518.PubMed
9.
Zurück zum Zitat Jalan R, Fernandez J, Wiest R et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310–1324.CrossRefPubMed Jalan R, Fernandez J, Wiest R et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60:1310–1324.CrossRefPubMed
11.
Zurück zum Zitat Albillos A, Martin-Mateos R, Van der Merwe S et al. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol. 2022;19:112–134.CrossRefPubMed Albillos A, Martin-Mateos R, Van der Merwe S et al. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol. 2022;19:112–134.CrossRefPubMed
12.
Zurück zum Zitat Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N Engl J Med. 2021;384:2317–2330.CrossRefPubMed Bajaj JS, Kamath PS, Reddy KR. The evolving challenge of infections in cirrhosis. N Engl J Med. 2021;384:2317–2330.CrossRefPubMed
13.
Zurück zum Zitat Biggins SW, Angeli P, Garcia-Tsao G et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014–1048.CrossRefPubMed Biggins SW, Angeli P, Garcia-Tsao G et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1014–1048.CrossRefPubMed
14.
Zurück zum Zitat European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397–417.CrossRef European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397–417.CrossRef
15.
Zurück zum Zitat Orman ES, Hayashi PH, Bataller R et al. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol. 2014;12:496-503.e1.CrossRefPubMed Orman ES, Hayashi PH, Bataller R et al. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol. 2014;12:496-503.e1.CrossRefPubMed
16.
Zurück zum Zitat Gaetano JN, Micic D, Aronsohn A et al. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016;31:1025–1030.CrossRefPubMed Gaetano JN, Micic D, Aronsohn A et al. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016;31:1025–1030.CrossRefPubMed
17.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Slim K, Nini E, Forestier D et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73:712–716.CrossRefPubMed Slim K, Nini E, Forestier D et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73:712–716.CrossRefPubMed
20.
Zurück zum Zitat Jesudian A, Barraza L, Steel P et al. Quality improvement initiative increases total paracentesis and early paracentesis rates in hospitalised cirrhotics with ascites. Frontline Gastroenterol. 2020;11:22–27.CrossRefPubMed Jesudian A, Barraza L, Steel P et al. Quality improvement initiative increases total paracentesis and early paracentesis rates in hospitalised cirrhotics with ascites. Frontline Gastroenterol. 2020;11:22–27.CrossRefPubMed
21.
Zurück zum Zitat Kim JJ, Tsukamoto MM, Mathur AK et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109:1436–1442.CrossRefPubMed Kim JJ, Tsukamoto MM, Mathur AK et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109:1436–1442.CrossRefPubMed
22.
Zurück zum Zitat Tocia C, Dumitru A, Alexandrescu L et al. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis. World J Hepatol. 2020;12:1267–1275.CrossRefPubMedPubMedCentral Tocia C, Dumitru A, Alexandrescu L et al. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis. World J Hepatol. 2020;12:1267–1275.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Rosenblatt R, Tafesh Z, Shen N et al. Early paracentesis in high-risk hospitalized patients: time for a new quality indicator. Am J Gastroenterol. 2019;114:1863–1869.CrossRefPubMed Rosenblatt R, Tafesh Z, Shen N et al. Early paracentesis in high-risk hospitalized patients: time for a new quality indicator. Am J Gastroenterol. 2019;114:1863–1869.CrossRefPubMed
24.
Zurück zum Zitat Salameh HM, Saraireh H, Petros V et al. Are we less compliant with early paracentesis than ever? and how is paracentesis timing related to in-hospital mortality? Analysis of nationwide inpatient sample data in 2013. Gastroenterology. 2017;152:S1079.CrossRef Salameh HM, Saraireh H, Petros V et al. Are we less compliant with early paracentesis than ever? and how is paracentesis timing related to in-hospital mortality? Analysis of nationwide inpatient sample data in 2013. Gastroenterology. 2017;152:S1079.CrossRef
25.
Zurück zum Zitat Gourineni V, Lee EJ, Loeser CS. A survey of residents to identify the limiting factors in performing early diagnostic paracentesis. Am J Gastroenterol 2015;110:S888.CrossRef Gourineni V, Lee EJ, Loeser CS. A survey of residents to identify the limiting factors in performing early diagnostic paracentesis. Am J Gastroenterol 2015;110:S888.CrossRef
26.
Zurück zum Zitat Fazel Y, Copetti APP, Onyechi E et al. QUALITY IMPROVEMENT: EARLY PARACENTESIS IN PATIENTS WITH CIRRHOSIS AND ASCITES. Gastroenterology 2022;162:S-117-S-1.CrossRef Fazel Y, Copetti APP, Onyechi E et al. QUALITY IMPROVEMENT: EARLY PARACENTESIS IN PATIENTS WITH CIRRHOSIS AND ASCITES. Gastroenterology 2022;162:S-117-S-1.CrossRef
27.
Zurück zum Zitat Grabau CM, Crago SF, Hoff LK et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488.CrossRefPubMed Grabau CM, Crago SF, Hoff LK et al. Performance standards for therapeutic abdominal paracentesis. Hepatology. 2004;40:484–488.CrossRefPubMed
28.
Zurück zum Zitat Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146:2259–2261.CrossRefPubMed Runyon BA. Paracentesis of ascitic fluid. A safe procedure. Arch Intern Med. 1986;146:2259–2261.CrossRefPubMed
29.
Zurück zum Zitat McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171.CrossRefPubMed McVay PA, Toy PT. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 1991;31:164–171.CrossRefPubMed
30.
Zurück zum Zitat Fernandez J, Prado V, Trebicka J et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol. 2019;70:398–411.CrossRefPubMed Fernandez J, Prado V, Trebicka J et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol. 2019;70:398–411.CrossRefPubMed
31.
Zurück zum Zitat Bajaj JS, O’Leary JG, Tandon P et al. Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis. Am J Gastroenterol. 2019;114:1091–1100.CrossRefPubMedPubMedCentral Bajaj JS, O’Leary JG, Tandon P et al. Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis. Am J Gastroenterol. 2019;114:1091–1100.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Fiore M, Maraolo AE, Gentile I et al. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol. 2017;9:1166–1175.CrossRefPubMedPubMedCentral Fiore M, Maraolo AE, Gentile I et al. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol. 2017;9:1166–1175.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Fiore M, Di Franco S, Alfieri A et al. Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments. Expert Rev Gastroenterol Hepatol. 2019;13:683–692.CrossRefPubMed Fiore M, Di Franco S, Alfieri A et al. Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments. Expert Rev Gastroenterol Hepatol. 2019;13:683–692.CrossRefPubMed
34.
Zurück zum Zitat Fernandez J, Acevedo J, Castro M et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55:1551–1561.CrossRefPubMed Fernandez J, Acevedo J, Castro M et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55:1551–1561.CrossRefPubMed
35.
Zurück zum Zitat Badal BD, Silvey S, Dragilev L et al. Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration. Hepatology. 2023;77:2030–2040.CrossRefPubMed Badal BD, Silvey S, Dragilev L et al. Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration. Hepatology. 2023;77:2030–2040.CrossRefPubMed
Metadaten
Titel
Diagnostic Paracentesis Within 1 Day Is Associated With Reduced Mortality and Length of Hospital Stay in Patients with Cirrhosis and Ascites
verfasst von
Joyce Badal
Bryan Badal
Mohamad Nawras
Wade Lee-Smith
Sara Stanley
Mona Hassan
Zohaib Ahmed
Publikationsdatum
13.01.2024
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2024
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-023-08249-w

Weitere Artikel der Ausgabe 4/2024

Digestive Diseases and Sciences 4/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.